AWA
VRTX icon

Aaron Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Aaron Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Sell
5,021
-21
-0.4% -$9.31K 0.13% 103
2026
Q1 		$2.25M Buy
5,042
+117
+2% +$54.6K 0.13% 98
2025
Q4 		$2.23M Buy
4,925
+1,003
+26% +$432K 0.12% 112
2025
Q3 		$1.54M Buy
3,922
+703
+22% +$294K 0.09% 154
2025
Q2 		$1.43M Sell
3,219
-88
-3% -$40.6K 0.15% 97
2025
Q1 		$1.6M Buy
3,307
+193
+6% +$89.9K 0.18% 76
2024
Q4 		$1.25M Sell
3,114
-72
-2% -$33.4K 0.15% 92
2024
Q3 		$1.48M Buy
3,186
+245
+8% +$118K 0.18% 81
2024
Q2 		$1.38M Buy
2,941
+245
+9% +$106K 0.19% 72
2024
Q1 		$1.13M Buy
2,696
+139
+5% +$58.8K 0.16% 82
2023
Q4 		$1.04M Buy
2,557
+61
+2% +$22.5K 0.17% 74
2023
Q3 		$868K Buy
2,496
+15
+0.6% +$5.25K 0.11% 95
2023
Q2 		$873K Buy
2,481
+40
+2% +$13.5K 0.11% 100
2023
Q1 		$769K Buy
2,441
+260
+12% +$78K 0.11% 108
2022
Q4 		$630K Sell
2,181
-198
-8% -$60.3K 0.09% 129
2022
Q3 		$689K Buy
2,379
+47
+2% +$13.5K 0.13% 93
2022
Q2 		$657K Sell
2,332
-589,026
-100% -$158M 0.17% 81
2022
Q1 		$2.27M Buy
591,358
+589,067
+25,712% +$140M 0.03% 217
2021
Q4 		$503K Buy
+2,291
New +$445K 0.14% 97

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Aaron Wealth Advisors's VRTX Position: Q2 2026 in Review

Aaron Wealth Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 0.42% in Q2 2026, selling an estimated $9.31K and leaving 5,021 shares worth $2.49M. The position accounts for 0.13% of the portfolio, ranked #103.

Aaron Wealth Advisors first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Aaron Wealth Advisors held 5,021 shares of Vertex Pharmaceuticals worth $2.49M as of Q2 2026.
  • Aaron Wealth Advisors sold 21 Vertex Pharmaceuticals shares in Q2 2026, an estimated $9.31K.
  • Vertex Pharmaceuticals made up 0.13% of Aaron Wealth Advisors's portfolio in Q2 2026, its #103 holding.
  • Aaron Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.